SENSEX NIFTY

Indian Pharma

Oct 07, 2014 at 22:18 | Source: CNBC-TV18
It's that time of the year when Forbes celebrates the outstanding contributions to the Indian arena of business. Inmobi won the award for outstanding start-up of the year, Shriram Transport Finance was named conscious capitalist of the year. The biggest honour went to Dilip Sanghvi of Sun Pharma, who was crowned the entrepreneur of the year.
Oct 01, 2014 at 11:53 | Source: CNBC-TV18
Deven Choksey, Managing Director of KR Choksey Shares and Securities advises investors to hold heavyweights such as FMCG, pharma, IT and start accumulating infra, commodities, auto stocks at lower levels.
Sep 30, 2014 at 08:19 | Source: CNBC-TV18
Tata Chemicals | Strides Arcolab | HDIL | IDFC | Shasun Pharma | Den Networks | Reliance Communications | SAIL | Essar Ports | Sudarshan Chemicals | Bhushan Steel and DCB Bank are stocks, which are in the news today.
Sep 24, 2014 at 11:51 | Source: CNBC-TV18
Market Analyst Satish Ramanathan Ramanathan says Indian investors should have a decent coverage of largecap companies and should buy quality stocks on dips.
Sep 23, 2014 at 13:20 | Source: Moneycontrol.com
In a research report, JPMorgan analysed companies that will likely be impacted the most from the recent currency-rate volatility, either by virtue of having direct operations in the Euro area or exporting to it.
Sep 12, 2014 at 16:00 | Source: CNBC-TV18
Despite the recent run up in pharma stocks, this week, problems related to the US FDA have made a come back. Jagdish Malkani, member at BSE and NSE believes though the Indian pharmaceuticals industry is a great play, investors should not get carried away with it.
Sep 12, 2014 at 13:41 | Source: CNBC-TV18
Krish Subramanyam of Asit C Mehta Investment Intermediates is of the view that one can buy Alembic for a target price of Rs 47 and Indian Oil Corporation for a target price of Rs 410.
Sep 11, 2014 at 13:21 | Source: Moneycontrol.com
According to CARE Ratings, patent expiration in the USA is a great news for not only consumers, with cheaper generics available in the market; but also for the Indian Pharmaceutical industry where generics account for approximately 75% of the total sales, says the report.
Sep 11, 2014 at 09:00 | Source: PTI
Indian pharmaceutical companies have an opportunity to capitalise on the patent cliff and gain a greater share of the growing generics market.
Sep 10, 2014 at 10:10 | Source: CNBC-TV18
The Indian market has been moving higher on positive domestic developments; other emerging markets have done well because of strong global inflows, but given the global cues one could see a tactical correction in emerging markets, Jyotivardhan Jaipuria, Head of Research, BofA ML says.
Messages on Indian Pharma »

Accolade

Gold Member

36 Followers

Dion Global  

Parvinder Singh Father of Malvinder and Shivinder built Ranbaxy from the scratch. Made it one of the most respected Indian pharma company globally. Had Parvinder alive, Ranbaxy would never have been sold off to Dia Ichi. Unfortunately like father not sons. Sons are manipulators. Sooner or later

10.57 PM Jul 4th

sikandar

Gold Member

12 Followers

Dr Reddys Labs  

to be the best company. But Sun set benchmarks in the Indian Pharma space in terms of high growth and high profitability. Of course, Sun is an admirable challenge and I think they have done it brilliantly. Their profitability has been industry leading from a long time. However, I don`t feel that we are less than

9.09 PM Jun 30th

MMB Messenger

Platinum Member

250910 Followers

Other Market Topics  

Will the Indian pharma industries be able to put behind its issues with FDA?

2.52 PM Jun 20th

MMB Messenger

Platinum Member

250910 Followers

Cipla  

Are you bullish on the Indian pharma sector?

3.21 PM Jun 19th

MMB Messenger

Platinum Member

250910 Followers

Cipla  

Are you bullish on Indian pharma sector?

1.40 PM Jun 19th

MMB Messenger

Platinum Member

250910 Followers

Other Market Topics  

Do you expect more such deals in the Indian pharma space?

8.35 PM Jun 11th

stocktin

Platinum Member

54 Followers

Biocon  

stage from Indian pharma companies be it Suven ,Glenmark ,Dr REddy, Cadilla,Sparc,Piramal life sciences & Biocon.For all u know innovation cd be the theme of this bull mkt in general also. The Indian pharma has managed to do wht the IT never even tried.So for me there is no choice of shifting

6.06 PM Jun 7th

smallman

Platinum Member

84 Followers

Wockhardt  

I donot think that ban by USFDA on Indian Pharma companies were simple Administrative/Hygenic decision. These were Political decision too, because India was reluctant to honour Patent Rights as approved by USFDA, in toto. I also expect that Modi`s visit to USA in September would improve the status

10.52 AM Jun 6th

01051982

New Member

1 Followers

Wockhardt  

It takes 2 to 3 years to get USFDA approval after getting alerts.( Considering the case of aurobindo pharma & other Indian pharma companies).Chikhalthana plant got fda alert n November 2013 so the plant will get approval by the end of FY 16 or in FY 17.If US plant get FDA alert ( Most likely

1.42 PM Jun 5th

cjvora

Gold Member

41 Followers

Sun Pharma  

sure touch sun best indian pharma stock gem of pharma stock 700 in short term and 1 year time touch 1000......just accumulate this stock and hold it tight for long term,sure big profit get!....good luck.

11.17 AM Jun 3rd

News across the web »
Sep 27, 2014 at 13:17 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.